This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
News: Congress

News and views from EAS 2019 Maastricht: Video interviews Late breaking session on Monday

Tuesday 28 May 2019   (0 Comments)
Share |

Dr. Antonio J. Vallejo-Vaz (Imperial College, London,UK) discusses a post hoc analysis of the 4S trial focusing on patients with a likely genetic vulnerability to high cholesterol – ‘FH phenotype’


Professor Derick Raal (University of the Witwatersrand, Johannesburg, South Africa) discusses ORION-2, a proof-of concept study with the siRNA inclisiran in homozygous familial hypercholesterolemia


Professor Evan Stein ((LIB Therapeutics and Metabolic & Atherosclerosis Research Center, Cincinnati, USA) discusses findings from a phase 2 trial with LIB003, a novel agent targeting PCSK9


Dr. Christie Ballantyne (Baylor College of Medicine, Houston, Texas, USA) discusses a trial with the fixed combination of bempedoic acid and ezetimibe in high risk patients not at LDL-C goal.


Membership Software Powered by YourMembership  ::  Legal